GPCR/G protein


All GPCRs share a common seven trans-membrane structure. GPCRs are associated with heterotrimeric G-proteins which are GTP-binding proteins made of alpha, beta, and gamma subunits. When a ligand binds to GPCR, it activates the attached G-protein, the GDP is replaced with GTP. The activated G-protein then dissociates into an alpha and a beta-gamma complex which activates downstream signaling pathways. These intracellular signaling pathways include cAMP/PKA, calcium/NFAT, phospholipase C, protein tyrosine kinases, MAP kinases, PI-3-kinase, nitric oxide/cGMP, Rho, and JAK/STAT.
GPCRs are one of the most important therapeutic targets for various diseases, over 30% of all modern medicinal drugs target this family. Aberrant GPCR functions are involved in pathological conditions such as neurological, immunological and hormonal disorders. A large number of GPCRs have been identified, but whose ligands are not known, are classified as orphan receptors.
-
B5452 CRSP-1Summary: Endogenous central calcitonin (CT) receptor agonist -
B5458 GRK2iSummary: GRK2 inhibitory polypeptide that specifically inhibits Gβγ activation of GRK2 -
B5459 Lys-γ3-MSHSummary: Pro-opiomelanocortin (POMC) derived peptide that stimulates lipolysis -
B5461 NovokininSummary: Angiotensin AT2 receptor agonist -
B5464 M 1145Summary: galanin receptor 2 (GAL2) agonist -
B5465 Neuropeptide SF (mouse, rat)Summary: neuropeptide FF receptor agonist -
B5466 Neuromedin S (rat)Summary: endogenous neuromedin U receptor agonist -
B5472 Boc-MLFSummary: formyl peptide receptor 1 (FPR1) antagonist -
B5476 Hemopressin (human, mouse)Summary: CB1 receptor inverse agonist; endogenous peptide substrate for endopeptidase 24.15 (ep24.15), neurolysin (ep24.16) and ACE -
B5480 MCH (human, mouse, rat)Summary: melanin-concentration hormone (MCH) receptors agonist

